EUVIMEDEUVIMED entdecken
Crossref

Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt

Saleh A Alqahtani, Yusuf Yilmaz, Mohamed El-Kassas iD, Khalid Alswat, Faisal Sanai iD, May AlZahrani, Faisal Abaalkhail, Manal AlShaikh, Waleed K Al-Hamoudi, Fatema Nader, Maria Stepanova, Zobair M Younossi iD und 1 weitere

Journal of Viral Hepatitis · 2024

DOI: 10.1111/jvh.13935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Saleh A Alqahtani und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Global NASH Council, Washington, DC, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Hepatitis C, Chronic, Hepatitis B, Chronic, Quality of Life. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with chronic liver disease (CLD) experience health‐related quality of life (HRQoL) and patient‐reported outcomes (PROs) impairments. We assessed and identified predictors of HRQoL and PROs in CLD patients from Saudi Arabia (SA), Turkey and Egypt. Patients enrolled in Global Liver Registry™ with chronic hepatitis B (CHB), chronic hepatitis C (CHC) and non‐alcoholic fatty liver disease (NAFLD) or non‐alcoholic steatohepatitis (NASH) were included. Clinical data and PRO questionnaires (FACIT‐F, CLDQ and WPAI) were compared across countries. Linear regression identified PRO predictors. Of the 4014 included patients, 26.9% had CHB, 26.9% CHC and 46.1% NAFLD/NASH; 19.2% advanced fibrosis. Compared across countries, CHB patients were younger in Egypt (mean age [years] 41.2 ± 11.4 vs. 45.0 ± 10.3 SA, 46.1 ± 12.0 Turkey), most often employed in SA (64.8% vs. 53.2% Turkey) and had the lowest prevalence of obesity in Turkey (26.7% vs. 37.8% SA, 38.5% Egypt). In SA, CHB patients had lowest prevalence of fibrosis and comorbidities (all p < .01). There was a higher frequency of males with NAFLD/NASH in SA (70.0% vs. 49.6% Turkey, and 35.5% Egypt). Among NAFLD/NASH patients, CLDQ‐NAFLD/NASH scores were highest in SA (mean total score: 5.3 ± 1.2 vs. 4.8 ± 1.2 Turkey, 4.1 ± 0.9 Egypt, p < .01). Independent predictors of worse PROs included younger age, female sex, advanced fibrosis, non‐hepatic comorbidities and lack of regular exercise (all p < .05). Clinical presentation and PRO scores of CLD patients vary across SA, Turkey and Egypt. Impairment of HRQoL is associated with demographic factors, lack of regular exercise, advanced fibrosis and non‐hepatic comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHepatitis C, ChronicHepatitis B, ChronicQuality of LifePatient Reported Outcome MeasuresHumansFemaleMaleAdultMiddle AgedSaudi ArabiaEgyptTurkeySurveys and QuestionnairesLiver Cirrhosis

Stichwörter der Autor:innen

CLDHRQoLagecomorbiditiesexercisefemale

Autor:innen und Institutionen

  • The Global NASH Council, Washington, DC, USA.
  • Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.
  • Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
  • Department of Medicine, Liver Disease Research Centre, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Mohamed El-Kassas, Faisal Sanai, Zobair M Younossi

Zitieren

APA

Alqahtani, S. A., Yilmaz, Y., El-Kassas, M., Alswat, K., Sanai, F., AlZahrani, M., Abaalkhail, F., AlShaikh, M., Al-Hamoudi, W. K., Nader, F., Stepanova, M., Younossi, Z. M., & Global NASH Council (2024). Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13935

Vancouver

Alqahtani SA, Yilmaz Y, El-Kassas M, Alswat K, Sanai F, AlZahrani M, et al. Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.13935

BibTeX
@article{Alqahtani2024,
  author = {Alqahtani, Saleh A and Yilmaz, Yusuf and El-Kassas, Mohamed and Alswat, Khalid and Sanai, Faisal and AlZahrani, May and Abaalkhail, Faisal and AlShaikh, Manal and Al-Hamoudi, Waleed K and Nader, Fatema and Stepanova, Maria and Younossi, Zobair M and Global NASH Council, Global NASH Council},
  title = {Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt},
  journal = {Journal of Viral Hepatitis},
  year = {2024},
  doi = {10.1111/jvh.13935}
}
Kostenlos starten →